CVS Health (CVS) Lifted to Overweight at Morgan Stanley


The company has a market capitalization of $79,800.00, a PE ratio of 16.28, a price-to-earnings-growth ratio of 1.25 and a beta of 0.90. Among active positions in the latest quarter, 654 holders increased their positions by a total of 49.63 million shares, 802 holders decreased the positions by a total of 46.37 million shares, and 142 holders held their positions. 7,096,589 shares of the company's stock traded hands, compared to its average volume of 10,770,000.

CVS Health (NYSE:CVS) was upgraded by equities researchers at UBS Group from an "outperform" rating to a "strong-buy" rating in a research report issued to clients and investors on Thursday, January 4th, The Fly reports. It has underperformed by 16.70% the S&P500.

David Dreman increased its stake in Teva Pharmaceutical Industries Ltd. (TEVA) by 168.75% based on its latest 2017Q3 regulatory filing with the SEC. Coho Partners Ltd sold 148,246 shares as the company's stock declined 4.23% while stock markets rallied. The Teachers Insurance & Annuity Association Of America holds 179,349 shares with $6.01 million value, up from 156,033 last quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator's stock valued at $2,353,000 after purchasing an additional 982 shares in the last quarter. About 189,475 shares traded. (NASDAQ:TTWO) has risen 81.23% since January 13, 2017 and is uptrending. It has underperformed by 19.46% the S&P500.

Investors sentiment increased to 1.15 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. The company has volume of 7.12 Million shares.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. Pennsylvania-based Susquehanna Llp has invested 0.01% in CVS Health Corporation (NYSE:CVS).

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company.

More news: Major League Baseball trade rumors: Yankees target Gerrit Cole traded to Astros
More news: Qudoos Bizenjo of PML-Q elected as new Balochistan Chief Minister
More news: Walgreens Boots Alliance, Inc. (NASDAQ:WBA) To Release Earnings

Pacific Heights Asset Management Llc, which manages about $9.65 billion and $1.05 billion US Long portfolio, decreased its stake in Hollyfrontier Corp (NYSE:HFC) by 50,000 shares to 275,000 shares, valued at $9.89M in 2017Q3, according to the filing. 0 analysts say it's a Hold while 0 analysts provided their expert opinion as Sell. Hyman Charles D holds 2,850 shares. M&T Bancorporation accumulated 293,327 shares. North Tide Capital Ltd Liability Company has invested 4.34% in CVS Health Corporation (NYSE:CVS). Gould Asset Management LLC CA now owns 4,785 shares of the pharmacy operator's stock valued at $376,000 after buying an additional 930 shares during the period. 4,100 are owned by Westwood Mngmt Corporation Il. Proshare Advisors Ltd Llc holds 8,306 shares or 0% of its portfolio. Ameriprise Inc reported 0.04% stake. Therefore 27% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. Argus reissued a "buy" rating and issued a $85.00 price objective (down from $120.00) on shares of CVS Health Corporation in a research note on Thursday, November 10th. S&P Research has "Strong Buy" rating and $112 target. Hayek Kallen Investment Management boosted its position in CVS Health by 6.5% during the 1st quarter. The stock presently has an average rating of "Buy" and an average target price of $86.66. The company was maintained on Tuesday, November 7 by Loop Capital. On Thursday, December 17 the stock rating was downgraded by Goldman Sachs to "Neutral".

Since August 16, 2017, it had 0 insider buys, and 7 selling transactions for $58.32 million activity. 39,340 CVS Health Corporation (NYSE:CVS) shares with value of $3.22M were sold by Foulkes Helena. Alliancebernstein Limited Partnership invested in 0.15% or 1.91M shares. It also reduced its holding in Monster Beverage Corp by 147,737 shares in the quarter, leaving it with 504,661 shares, and cut its stake in Liberty Media Corporation (Prn).

Investors sentiment increased to 1.32 in 2017 Q3. Its up 0.02, from 0.94 in 2017Q2. It dropped, as 14 investors sold AXTI shares while 25 reduced holdings. Greenwood Capital Associate Llc holds 1.48% or 166,921 shares in its portfolio. The company has a total of 1.17 Billion shares outstanding. Employees Retirement System Of Ohio invested 0.04% of its portfolio in MSCI Inc. Shares for $614,600 were sold by Dornemann Michael. Cambridge Trust holds 13,349 shares or 0.07% of its portfolio. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator's stock valued at $108,000 after purchasing an additional 726 shares in the last quarter. Eqis Mgmt invested 0.01% in Prestige Brands Holdings, Inc. (NYSE:PFE). Strategic has 133,674 shares. Thompson Siegel Walmsley holds 5,400 shares. Addenda holds 0.36% or 63,703 shares. Piermont Capital Mgmt holds 0.3% or 18,220 shares in its portfolio. (NYSE:MSCI) or 737,298 shares. Trustmark National Bank & Trust Department owns 2,822 shares.

Since August 23, 2017, it had 0 insider buys, and 4 insider sales for $69.60 million activity. The insider MACKENZIE ALEXANDER R sold $249,750. Ballentine Prns Limited Co invested in 8,795 shares. Endurance Wealth Mngmt holds 1.57% or 116,428 shares. READ IAN C sold $3.30 million worth of stock. Weaver C Barksdale Assoc owns 94 shares. Profit Investment Management Llc sold 12,033 shares as the company's stock rose 13.22% with the market. Therefore 43% are positive. Regency Centers Corporation had 57 analyst reports since July 21, 2015 according to SRatingsIntel. UBS maintained Pfizer Inc. On Friday, June 9 the stock rating was maintained by Jefferies with "Hold". They issued a "buy" rating and a $90.00 target price for the company. Firm's net income measured an average growth rate of -7.00%. The stock of AXT, Inc. The company was maintained on Thursday, October 26 by Northland Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.